A targeted, short-term cognitive training regimen designed to accelerate visual information processing has demonstrated a significant and enduring protective effect against the development of dementia, including Alzheimer’s disease, for up to twenty years post-intervention. This groundbreaking finding emerges from a comprehensive, longitudinal study that tracked a large cohort of older adults for two decades, providing compelling evidence for the lasting benefits of a specific type of cognitive exercise. The research, published in the esteemed journal Alzheimer’s & Dementia: Translational Research and Clinical Interventions, offers a novel perspective on non-pharmacological strategies for dementia prevention.
The cornerstone of this investigation was the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study, a pioneering randomized clinical trial funded by the National Institutes of Health (NIH). Initiated between 1998 and 1999, the ACTIVE study enrolled 2,802 older adults who were then randomly assigned to one of three distinct cognitive training arms or a control group that received no structured cognitive intervention. The objective was to rigorously assess the long-term impact of different cognitive exercises on various cognitive domains and, crucially, on dementia incidence.
The three intervention groups underwent distinct training programs: one focused on memory enhancement, another on reasoning skills, and the third, which proved to be the most impactful, centered on improving the speed at which individuals process visual information. Participants in these training groups engaged in up to ten sessions, each lasting between 60 and 75 minutes, spread over a period of five to six weeks. A significant aspect of the study design involved a subset of participants being further randomized to receive additional "booster" sessions at approximately 11 and 35 months following the initial training, aiming to reinforce the learned skills and potentially extend their benefits.
The findings from the twenty-year follow-up are particularly striking. Researchers meticulously analyzed long-term health outcomes for the study participants. Among those who completed the speed of processing training and received the booster sessions, a notably lower proportion, 105 out of 264 individuals (approximately 40%), were diagnosed with dementia. In stark contrast, within the control group, which did not receive any specific cognitive training, 239 out of 491 participants (approximately 49%) developed dementia over the same period. This translates to a statistically significant 25% reduction in dementia incidence among those who engaged in the enhanced speed training program. Crucially, speed of processing training was the sole intervention that exhibited a statistically significant protective effect when compared to the control group, underscoring its unique efficacy.
To ascertain dementia diagnoses over such an extended period, researchers relied on comprehensive review of Medicare records for 2,021 participants, representing 72% of the original cohort, spanning from 1999 to 2019. This follow-up cohort accurately mirrored the demographic characteristics of the initial study population, with approximately three-quarters being female, 70% identifying as White, and an average age of 74 at the study’s commencement. Over the two-decade span of the study, a substantial majority of participants, roughly 75%, passed away, with an average age of 84.
The profound implications of preventing dementia cannot be overstated, given its devastating impact on individuals, families, and healthcare systems. Dementia is characterized by a progressive decline in cognitive functions, including thinking and memory, to a degree that significantly impairs daily life and the ability to live independently. Current estimates suggest that a substantial proportion of adults over the age of 55 will experience dementia at some point in their lives, and the economic burden on the United States alone exceeds $600 billion annually. Alzheimer’s disease represents the most common form, accounting for 60% to 80% of all dementia cases, followed by vascular dementia (5% to 10%), and other forms such as Lewy body dementia, frontotemporal dementia, and mixed dementia.
Marilyn Albert, Ph.D., the corresponding author of the study and director of the Alzheimer’s Disease Research Center at Johns Hopkins Medicine, commented on the significance of these findings. "Seeing that boosted speed training was linked to lower dementia risk two decades later is remarkable because it suggests that a fairly modest nonpharmacological intervention can have long-term effects," she stated. Dr. Albert further emphasized the public health potential, noting, "Even small delays in the onset of dementia may have a large impact on public health and help reduce rising health care costs." However, she also pointed out the need for further research to elucidate the underlying biological mechanisms responsible for these observed benefits and to understand why memory and reasoning training did not yield the same long-term protective associations in this study.
These new results build upon earlier findings from the ACTIVE trial, which had previously demonstrated that cognitive training could enhance everyday thinking skills for up to five years. A decade into the study, all three types of cognitive training interventions were associated with improved daily functioning. Specifically, participants who underwent speed training showed a 29% lower incidence of dementia at the ten-year mark compared to the control group. The addition of booster sessions further correlated with additional reductions in dementia risk.
The researchers propose that the particular effectiveness of speed training may stem from its adaptive nature. The program was dynamically adjusted to the individual’s performance on a given day, presenting more challenging tasks to those who demonstrated proficiency and allowing individuals requiring more time to work at a pace suited to them. In contrast, the memory and reasoning training programs employed a more standardized approach, delivering the same strategies to all participants.
Furthermore, the study highlights the potential role of implicit learning in the success of speed training. Implicit learning, akin to skill or habit acquisition, operates differently from explicit learning, which involves conscious memorization of facts and techniques. Scientists recognize that these distinct learning processes engage different neural pathways within the brain. This divergence in neural engagement might offer an explanation for why speed training, which leans heavily on implicit learning, was uniquely associated with a reduced risk of dementia in this extensive analysis.
George Rebok, Ph.D., a site principal investigator for the study, a lifespan developmental psychologist, and professor emeritus of mental health at the Johns Hopkins Bloomberg School of Public Health, expressed his support for these findings. "Our findings provide support for the development and refinement of cognitive training interventions for older adults, particularly those that target visual processing and divided attention abilities," he remarked. He also suggested, "It is possible that adding this cognitive training to lifestyle change interventions may delay dementia onset, but that remains to be studied."
The study authors posit that speed training could potentially serve as a valuable complement to other established strategies for healthy aging that aim to maintain brain connectivity. However, they stress the necessity of further research to validate this hypothesis. Current evidence already links several lifestyle factors to a reduced risk of cognitive decline, including maintaining cardiovascular health through vigilant management of blood pressure, blood sugar, cholesterol, and body weight, alongside consistent engagement in regular physical activity.
The research team comprised a multidisciplinary group of scientists from various institutions, including Norma B. Coe, Chuxuan Sun, and Elizabeth Taggert from the University of Pennsylvania; Katherine E. M. Miller and Alden L. Gross from the Johns Hopkins Bloomberg School of Public Health; Richard N. Jones from Brown University; Cynthia Felix from the University of Pittsburgh; Michael Marsiske from the University of Florida; Karlene K. Ball from the University of Alabama at Birmingham; and Sherry L. Willis from the University of Washington. Funding for this significant study was provided by NIH grants from the National Institute on Aging (R01AG056486). The initial ACTIVE trial received extensive support through NIH grants awarded to multiple field sites and the coordinating center, encompassing institutions such as Hebrew Senior-Life, Boston; the Indiana University School of Medicine; The Johns Hopkins University; the New England Research Institutes; the Pennsylvania State University; the University of Alabama at Birmingham; and Wayne State University/University of Florida.
About the Author
